D.A. Davidson & Co’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,217
| Closed | -$8.29K | – | 1390 |
|
|
2023
Q1 | $8.29K | Hold |
2,217
| – | – | ﹤0.01% | 1324 |
|
|
2022
Q4 | $6.85K | Hold |
2,217
| – | – | ﹤0.01% | 1297 |
|
|
2022
Q3 | $10K | Sell |
2,217
-1,583
| -42% | -$7.14K | ﹤0.01% | 1264 |
|
|
2022
Q2 | $100K | Sell |
3,800
-450
| -11% | -$11.8K | ﹤0.01% | 1223 |
|
|
2022
Q1 | $158K | Hold |
4,250
| – | – | ﹤0.01% | 1231 |
|
|
2021
Q4 | $249K | Hold |
4,250
| – | – | ﹤0.01% | 1115 |
|
|
2021
Q3 | $349K | Sell |
4,250
-133
| -3% | -$10.9K | ﹤0.01% | 951 |
|
|
2021
Q2 | $414K | Sell |
4,383
-67
| -2% | -$6.33K | ﹤0.01% | 886 |
|
|
2021
Q1 | $284K | Sell |
4,450
-133
| -3% | -$8.49K | ﹤0.01% | 972 |
|
|
2020
Q4 | $267K | Hold |
4,583
| – | – | ﹤0.01% | 883 |
|
|
2020
Q3 | $96K | Sell |
4,583
-884
| -16% | -$18.5K | ﹤0.01% | 923 |
|
|
2020
Q2 | $86K | Buy |
5,467
+1,800
| +49% | +$28.3K | ﹤0.01% | 910 |
|
|
2020
Q1 | $48K | Hold |
3,667
| – | – | ﹤0.01% | 965 |
|
|
2019
Q4 | $76K | Buy |
3,667
+167
| +5% | +$3.46K | ﹤0.01% | 988 |
|
|
2019
Q3 | $112K | Buy |
3,500
+750
| +27% | +$24K | ﹤0.01% | 959 |
|
|
2019
Q2 | $60K | Sell |
2,750
-1,067
| -28% | -$23.3K | ﹤0.01% | 977 |
|
|
2019
Q1 | $147K | Buy |
3,817
+684
| +22% | +$26.3K | ﹤0.01% | 1066 |
|
|
2018
Q4 | $141K | Buy |
3,133
+583
| +23% | +$26.2K | ﹤0.01% | 1019 |
|
|
2018
Q3 | $111K | Hold |
2,550
| – | – | ﹤0.01% | 1129 |
|
|
2018
Q2 | $105K | Buy |
2,550
+767
| +43% | +$31.6K | ﹤0.01% | 1084 |
|
|
2018
Q1 | $50K | Sell |
1,783
-1,500
| -46% | -$42.1K | ﹤0.01% | 1091 |
|
|
2017
Q4 | $109K | Hold |
3,283
| – | – | ﹤0.01% | 1074 |
|
|
2017
Q3 | $157K | Hold |
3,283
| – | – | ﹤0.01% | 1043 |
|
|
2017
Q2 | $184K | Buy |
3,283
+250
| +8% | +$14K | ﹤0.01% | 997 |
|
|
2017
Q1 | $178K | Buy |
3,033
+133
| +5% | +$7.81K | ﹤0.01% | 990 |
|
|
2016
Q4 | $324K | Buy |
2,900
+1,900
| +190% | +$212K | 0.01% | 814 |
|
|
2016
Q3 | $126K | Buy |
+1,000
| New | +$126K | ﹤0.01% | 1144 |
|